Eisai Co., Ltd. is a global pharmaceutical company headquartered in Tokyo, Japan, with a strong legacy in neurology and oncology. Founded in 1941, Eisai is guided by its human health care (hhc) philosophy, which places patients and their families at the core of its innovation and decision-making. The company is committed to discovering and developing novel therapies that address unmet medical needs, particularly in neurological disorders such as epilepsy, Alzheimer’s disease, etc

With operations in over 80 countries, Eisai is dedicated to scientific research, patient access programs, and public health initiatives, ensuring that its treatments reach those in need. The company collaborates with leading healthcare professionals, research institutions, and advocacy groups to enhance disease awareness, improve treatment accessibility, and advance global health equity, reinforcing its mission to contribute to a better tomorrow for patients worldwide.